Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))

K. N. Westlund; M. A. Montera; A. E. Goins; S. R.A. Alles; M. Afaghpour-Becklund; R. Bartel; R. Durvasula; A. Kunamneni

doi:10.1016/j.ynpai.2023.100127

Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))

K. N. Westlund, M. A. Montera, A. E. Goins, S. R.A. Alles, M. Afaghpour-Becklund, R. Bartel, R. Durvasula, A. Kunamneni

Infectious Diseases

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret inadvertently missing the addition of the Animal ethical statement. Please see the intended statement below. The studies received formal approval from the Committee on Animal Research and Ethics (IACUC), at the Health Sciences Center, University of New Mexico. The experiments reported were performed in accordance with the recommendations of the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain. The authors would like to apologize for any inconvenience caused.

Original language	English (US)
Article number	100127
Journal	Neurobiology of Pain
Volume	14
DOIs	https://doi.org/10.1016/j.ynpai.2023.100127
State	Published - Aug 1 2023

ASJC Scopus subject areas

Neuroscience (miscellaneous)
Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1016/j.ynpai.2023.100127

Fingerprint

Dive into the research topics of 'Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))'. Together they form a unique fingerprint.

Cite this

Westlund, K. N., Montera, M. A., Goins, A. E., Alles, S. R. A., Afaghpour-Becklund, M., Bartel, R., Durvasula, R., & Kunamneni, A. (2023). Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067)). Neurobiology of Pain, 14, Article 100127. https://doi.org/10.1016/j.ynpai.2023.100127

Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067)). / Westlund, K. N.; Montera, M. A.; Goins, A. E. et al.
In: Neurobiology of Pain, Vol. 14, 100127, 01.08.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Westlund, KN, Montera, MA, Goins, AE, Alles, SRA, Afaghpour-Becklund, M, Bartel, R, Durvasula, R & Kunamneni, A 2023, 'Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))', Neurobiology of Pain, vol. 14, 100127. https://doi.org/10.1016/j.ynpai.2023.100127

Westlund KN, Montera MA, Goins AE, Alles SRA, Afaghpour-Becklund M, Bartel R et al. Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067)). Neurobiology of Pain. 2023 Aug 1;14:100127. doi: 10.1016/j.ynpai.2023.100127

@article{01f7c21b68a74ec8ba84c2763bc54df7,

title = "Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))",

abstract = "The authors regret inadvertently missing the addition of the Animal ethical statement. Please see the intended statement below. The studies received formal approval from the Committee on Animal Research and Ethics (IACUC), at the Health Sciences Center, University of New Mexico. The experiments reported were performed in accordance with the recommendations of the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain. The authors would like to apologize for any inconvenience caused.",

author = "Westlund, {K. N.} and Montera, {M. A.} and Goins, {A. E.} and Alles, {S. R.A.} and M. Afaghpour-Becklund and R. Bartel and R. Durvasula and A. Kunamneni",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

month = aug,

day = "1",

doi = "10.1016/j.ynpai.2023.100127",

language = "English (US)",

volume = "14",

journal = "Neurobiology of Pain",

issn = "2452-073X",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))

AU - Westlund, K. N.

AU - Montera, M. A.

AU - Goins, A. E.

AU - Alles, S. R.A.

AU - Afaghpour-Becklund, M.

AU - Bartel, R.

AU - Durvasula, R.

AU - Kunamneni, A.

PY - 2023/8/1

Y1 - 2023/8/1

N2 - The authors regret inadvertently missing the addition of the Animal ethical statement. Please see the intended statement below. The studies received formal approval from the Committee on Animal Research and Ethics (IACUC), at the Health Sciences Center, University of New Mexico. The experiments reported were performed in accordance with the recommendations of the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain. The authors would like to apologize for any inconvenience caused.

AB - The authors regret inadvertently missing the addition of the Animal ethical statement. Please see the intended statement below. The studies received formal approval from the Committee on Animal Research and Ethics (IACUC), at the Health Sciences Center, University of New Mexico. The experiments reported were performed in accordance with the recommendations of the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85152413969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152413969&partnerID=8YFLogxK

U2 - 10.1016/j.ynpai.2023.100127

DO - 10.1016/j.ynpai.2023.100127

M3 - Comment/debate

AN - SCOPUS:85152413969

SN - 2452-073X

VL - 14

JO - Neurobiology of Pain

JF - Neurobiology of Pain

M1 - 100127

ER -

Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067] (Neurobiology of Pain (2021) 10, (S2452073X21000088), (10.1016/j.ynpai.2021.100067))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this